UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Journal of physiology, ISSN 0022-3751, 07/2016, Volume 594, Issue 13, pp. 3521 - 3531
Schwann Cells - physiology | Myelin Sheath - physiology | Nervous System Diseases - physiopathology | Animals | Humans | Nerve Regeneration - physiology | Physiological aspects | Analysis | Neurophysiology | Spinal cord injuries | Index Medicus | Axon regeneration and remyelination in the peripheral and central nervous systems | Symposium Review | Symposium section reviews | Neurological Conditions, Disorders and Treatments | Cellular and Molecular Neuroscience
Journal Article
Neurobiology of disease, ISSN 0969-9961, 06/2019, Volume 126, pp. 5 - 12
Stroke | Oligodendrocyte | Myelin | White matter stroke | Oligodendrocyte precursor cell, remyelination | Activity dependent remyelination | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Stroke - pathology | Demyelinating Diseases - physiopathology | Animals | Aging - physiology | Humans | Remyelination - physiology | Brain - pathology | Demyelinating Diseases - pathology | Aging - pathology | White Matter - pathology | Aged | Dementia | Index Medicus
Journal Article
Biomaterials, ISSN 0142-9612, 07/2015, Volume 56, pp. 78 - 85
Journal Article
Journal of neuroinflammation, ISSN 1742-2094, 08/2019, Volume 16, Issue 1, pp. 165 - 165
Neurosciences | Immunology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cuprizone - toxicity | Oligodendroglia - metabolism | Butyrates - pharmacology | Mice, Inbred C57BL | Myelin Sheath - drug effects | Male | Gastrointestinal Microbiome - physiology | Demyelinating Diseases - metabolism | Demyelinating Diseases - prevention & control | Myelin Sheath - metabolism | Animals | Gastrointestinal Microbiome - drug effects | Oligodendroglia - drug effects | Cell Differentiation - drug effects | Remyelination - physiology | Butyrates - therapeutic use | Demyelinating Diseases - chemically induced | Mice | Anti-Bacterial Agents - toxicity | Remyelination - drug effects | Cell Differentiation - physiology | Organ Culture Techniques | Development and progression | Multiple sclerosis | Care and treatment | Myelination | Microbiota (Symbiotic organisms) | Health aspects | Index Medicus | Short-chain fatty acids | Oligodendrocyte | Demyelination | Remyelination
Journal Article
Glia, ISSN 0894-1491, 12/2017, Volume 65, Issue 12, pp. 2087 - 2098
oligodendrocyte progenitor cells | demyelination | multiple sclerosis | gray matter | remyelination | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Age Factors | RNA, Untranslated - metabolism | Intracellular Signaling Peptides and Proteins - metabolism | Hippocampus - drug effects | Cell Lineage - drug effects | RNA, Untranslated - genetics | Cell Differentiation - genetics | Oligodendrocyte Precursor Cells - drug effects | Demyelinating Diseases - chemically induced | Demyelinating Diseases - pathology | Cell Lineage - genetics | Disease Models, Animal | Cuprizone - toxicity | Receptor, Platelet-Derived Growth Factor alpha - metabolism | Mice, Inbred C57BL | Bacterial Proteins - genetics | Corpus Callosum - drug effects | Mice, Transgenic | Hippocampus - pathology | Monoamine Oxidase Inhibitors - toxicity | Animals | Receptor, Platelet-Derived Growth Factor alpha - genetics | Corpus Callosum - pathology | Remyelination - physiology | Bacterial Proteins - metabolism | Luminescent Proteins - genetics | Mice | Remyelination - drug effects | Luminescent Proteins - metabolism | Medicine, Experimental | Medical research | Multiple sclerosis | Platelet-derived growth factor | Cortex (cingulate) | Myelin | Central nervous system | Axonal plasticity | Substantia alba | Substantia grisea | Glial stem cells | Corpus callosum | Atrophy | Regeneration | Myelination | Cuprizone | Sheaths | Demyelination | Oligodendrocytes | Cells (biology) | In vivo methods and tests | Differentiation | Cortex (temporal) | Index Medicus
Journal Article
Biomolecules (Basel, Switzerland), ISSN 2218-273X, 02/2021, Volume 11, Issue 2, p. 290
Journal Article
Glia, ISSN 0894-1491, 07/2018, Volume 66, Issue 7, pp. 1302 - 1316
myelin | differentiation | vitamin C | oligodendrocyte progenitor cell | oligodendrocyte | remyelination | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Coculture Techniques | Neurons - cytology | Ganglia, Spinal - cytology | Brain - physiology | Dose-Response Relationship, Drug | Neuroprotective Agents - pharmacology | Oligodendroglia - drug effects | Oligodendroglia - physiology | Cuprizone | Time Factors | Neurons - physiology | Female | Oligodendroglia - cytology | Demyelinating Diseases - pathology | Neurons - drug effects | Cell Differentiation - physiology | Demyelinating Diseases - drug therapy | Disease Models, Animal | Demyelinating Diseases - physiopathology | Brain - cytology | Ascorbic Acid - analogs & derivatives | Mice, Inbred C57BL | Ganglia, Spinal - physiology | Antioxidants - pharmacology | Brain - drug effects | Animals | Cell Differentiation - drug effects | Remyelination - physiology | Ascorbic Acid - pharmacology | Brain - pathology | Mice | Remyelination - drug effects | Ganglia, Spinal - drug effects | Multiple sclerosis | Analysis | Alternative medicine | Dietary supplements | Vitamin C | Neurophysiology | Cell culture | Ascorbic acid | Demyelinating diseases | Myelin | Central nervous system | Glial stem cells | Molecular chains | Antioxidants | Time dependence | Myelination | Diet | Restoration | Sheaths | Demyelination | Oligodendrocytes | Differentiation | Index Medicus
Journal Article
Multiple sclerosis, ISSN 1352-4585, 10/2018, Volume 24, Issue 11, pp. 1421 - 1432
Multiple sclerosis | demyelination | Xenopus laevis | oligodendrocyte | Crispr/Cas9 | transgenic | gene editing | remyelination | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Xenopus | Animals | Benzyl Compounds - pharmacology | Larva | Animals, Genetically Modified | Remyelination - physiology | Receptors, Lysosphingolipid - agonists | Female | Male | Azetidines - pharmacology | Remyelination - drug effects | Disease Models, Animal | CRISPR | Myelination | Optic nerve | Myelin | Demyelination | Oligodendrocytes | Nitroreductase | Green fluorescent protein | Metronidazole | Drug development | Sphingosine 1-phosphate | Index Medicus | Life Sciences
Journal Article
The Journal of neuroscience, ISSN 0270-6474, 2017, Volume 37, Issue 37, pp. 9086 - 9099
Nerve | Regeneration | PNS | Schwann cell | Injury | Remyelination | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Animals | Neuronal Outgrowth | Peripheral Nerve Injuries - physiopathology | Nerve Regeneration - physiology | Peripheral Nerve Injuries - pathology | Female | Male | Mice, Transgenic | Schwann Cells - pathology | Mice | Myelin Sheath - metabolism | Scanning electron microscopy | Myelin | Schwann cells | Cell lineage | Electron microscopy | Myelination | Banded structure | Nerves | Repair | Elongation | Injuries | Columns (structural) | Index Medicus | injury | regeneration | nerve | remyelination
Journal Article